Please assess the completion status of the following clinical trial:

Trial Title: Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Maternal age ≥ 18 years~* Preterm premature rupture of membranes, demonstrated clinically by speculum exam~* Cervical dilation visually ≤ 5cm on sterile speculum exam~* Planned delivery at John Sealy Hospital (JSH)~* Gestational age of membrane rupture and initiation of first course of antenatal corticosteroids between 23 5/7 - 32 5/7 weeks~* Planned pregnancy continuation with no indication for delivery for at least 7 days~Exclusion Criteria:~* Maternal age \> 50 years~* Gestational age \< 23 5/7 weeks or \> 32 5/7 weeks~* Known major congenital abnormalities, aneuploidy, or genetic syndrome~* Intrauterine fetal demise~* Any indication for expedited delivery~* Maternal chorioamnionitis~* Known allergy or adverse reaction to corticosteroids

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Betamethasone (Type: EXPERIMENTAL): Women admitted with PPROM who will receive a second course of two betamethasone 12mg intramuscular (IM) injections given 24 hours apart.
- Saline Placebo (Type: PLACEBO_COMPARATOR): Women admitted with PPROM who will receive intramuscular saline placebo, given as two injections 24 hours apart.

Based on this trial design, predict the completion outcome and termination type (if applicable).